{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:53:54Z","timestamp":1792799634799,"version":"4.5.0"},"reference-count":40,"publisher":"American Association for Cancer Research (AACR)","issue":"4","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50-CA083636"],"award-info":[{"award-number":["P50-CA083636"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01 CA152990"],"award-info":[{"award-number":["U01 CA152990"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["293438"],"award-info":[{"award-number":["293438"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"American Cancer Society Early Detection Professorship","award":["SIOP-06-258-01-COUN"],"award-info":[{"award-number":["SIOP-06-258-01-COUN"]}],"id":[{"id":"https:\/\/ror.org\/02e463172","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Recent insights supporting the fallopian tube epithelium (FTE) and serous tubal intraepithelial carcinomas (STIC) as the tissue of origin and the precursor lesion, respectively, for the majority of high-grade serous ovarian carcinomas (HGSOC) provide the necessary context to study the mechanisms that drive the development and progression of HGSOC. Here, we investigate the role of the E3 ubiquitin ligase RNF20 and histone H2B monoubiquitylation (H2Bub1) in serous tumorigenesis and report that heterozygous loss of RNF20 defines the majority of HGSOC tumors. At the protein level, H2Bub1 was lost or downregulated in a large proportion of STIC and invasive HGSOC tumors, implicating RNF20\/H2Bub1 loss as an early event in the development of serous ovarian carcinoma. Knockdown of RNF20, with concomitant loss of H2Bub1, was sufficient to enhance cell migration and clonogenic growth of FTE cells. To investigate the mechanisms underlying these effects, we performed ATAC-seq and RNA-seq in RNF20 knockdown FTE cell lines. Loss of RNF20 and H2Bub1 was associated with a more open chromatin conformation, leading to upregulation of immune signaling pathways, including IL6. IL6 was one of the key cytokines significantly upregulated in RNF20- and H2Bub1-depleted FTE cells and imparted upon these cells an enhanced migratory phenotype. These studies provide mechanistic insight into the observed oncogenic phenotypes triggered by the early loss of H2Bub1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Loss of RNF20 and H2Bub1 contributes to transformation of the fallopian tube epithelium and plays a role in the initiation and progression of high-grade serous ovarian cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-18-2297","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T15:24:25Z","timestamp":1545146665000},"page":"760-772","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer"],"prefix":"10.1158","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-6092","authenticated-orcid":false,"given":"Jagmohan","family":"Hooda","sequence":"first","affiliation":[{"name":"1Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1n","family":"Novak","sequence":"additional","affiliation":[{"name":"2Department of Medical Oncology, Dana-Farber Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Salomon","sequence":"additional","affiliation":[{"name":"3Department of Translational Molecular Medicine, John Wayne Cancer Institute, Providence Health Services, Santa Monica, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Matsuba","sequence":"additional","affiliation":[{"name":"3Department of Translational Molecular Medicine, John Wayne Cancer Institute, Providence Health Services, Santa Monica, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romela I.","family":"Ramos","sequence":"additional","affiliation":[{"name":"3Department of Translational Molecular Medicine, John Wayne Cancer Institute, Providence Health Services, Santa Monica, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8479-8512","authenticated-orcid":false,"given":"Emily","family":"MacDuffie","sequence":"additional","affiliation":[{"name":"2Department of Medical Oncology, Dana-Farber Institute, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Song","sequence":"additional","affiliation":[{"name":"1Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Hirsch","sequence":"additional","affiliation":[{"name":"4Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Lester","sequence":"additional","affiliation":[{"name":"5Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8880-9108","authenticated-orcid":false,"given":"Vinita","family":"Parkash","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Yale University, New Haven, Connecticut."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[{"name":"5Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Department of Obstetrics and Gynecology, Cedars-Sinai Medical Center, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Oren","sequence":"additional","affiliation":[{"name":"7Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave S.","family":"Hoon","sequence":"additional","affiliation":[{"name":"3Department of Translational Molecular Medicine, John Wayne Cancer Institute, Providence Health Services, Santa Monica, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-6977","authenticated-orcid":false,"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[{"name":"1Penn Ovarian Cancer Research Center, Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"2022061706315613500_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2022061706315613500_bib2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2022061706315613500_bib3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41467-017-01217-9","article-title":"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma","volume":"8","author":"Ducie","year":"2017","journal-title":"Nat Commun"},{"key":"2022061706315613500_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"key":"2022061706315613500_bib5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Cancer Discov"},{"key":"2022061706315613500_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"2022061706315613500_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2022061706315613500_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2013evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"2022061706315613500_bib9","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","volume":"1","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol"},{"key":"2022061706315613500_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2217\/fon.11.152","article-title":"Targeting the epigenome in ovarian cancer","volume":"8","author":"Murphy","year":"2012","journal-title":"Future Oncol"},{"key":"2022061706315613500_bib11","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/cncr.25701","article-title":"Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer","volume":"117","author":"Fu","year":"2011","journal-title":"Cancer"},{"key":"2022061706315613500_bib12","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/1078-0432.CCR-17-3055","article-title":"A phase I clinical trial of guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer: clinical, pharmacokinetic, and pharmacodynamic analyses","volume":"24","author":"Matei","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2022061706315613500_bib13","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1158\/1078-0432.CCR-18-0204","article-title":"An effective epigenetic-PARP inhibitor combination therapy for breast and ovarian cancers independent of BRCA mutations","volume":"24","author":"Pulliam","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2022061706315613500_bib14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.febslet.2012.04.002","article-title":"The enigmatic role of H2Bub1 in cancer","volume":"586","author":"Johnsen","year":"2012","journal-title":"FEBS Lett"},{"key":"2022061706315613500_bib15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbagrm.2014.01.002","article-title":"Writing and reading H2B monoubiquitylation","volume":"1839","author":"Fuchs","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2022061706315613500_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.molcel.2005.11.012","article-title":"The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions","volume":"20","author":"Kim","year":"2005","journal-title":"Mol Cell"},{"key":"2022061706315613500_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2009.02.027","article-title":"RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells","volume":"137","author":"Kim","year":"2009","journal-title":"Cell"},{"key":"2022061706315613500_bib18","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1101\/gad.1703008","article-title":"The histone H2B-specific ubiquitin ligase RNF20\/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression","volume":"22","author":"Shema","year":"2008","journal-title":"Genes Dev"},{"key":"2022061706315613500_bib19","doi-asserted-by":"crossref","first-page":"e36775","DOI":"10.1371\/journal.pone.0036775","article-title":"Coupling of glucose deprivation with impaired histone H2B monoubiquitination in tumors","volume":"7","author":"Urasaki","year":"2012","journal-title":"PLoS One"},{"key":"2022061706315613500_bib20","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.febslet.2011.07.034","article-title":"RNF20-RNF40: A ubiquitin-driven link between gene expression and the DNA damage response","volume":"585","author":"Shiloh","year":"2011","journal-title":"FEBS Lett"},{"key":"2022061706315613500_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"2022061706315613500_bib22","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/nprot.2012.097","article-title":"Primary culture and immortalization of human fallopian tube secretory epithelial cells","volume":"7","author":"Karst","year":"2012","journal-title":"Nat Protoc"},{"key":"2022061706315613500_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.gdata.2017.01.002","article-title":"Genome-wide chromatin accessibility, DNA methylation and gene expression analysis of histone deacetylase inhibition in triple-negative breast cancer","volume":"12","author":"Bustos","year":"2017","journal-title":"Genom Data"},{"key":"2022061706315613500_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"2022061706315613500_bib25","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"2022061706315613500_bib26","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"2022061706315613500_bib27","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706315613500_bib28","doi-asserted-by":"crossref","first-page":"8007","DOI":"10.1128\/JVI.00334-10","article-title":"Multiple DNA damage signaling and repair pathways deregulated by simian virus 40 large T antigen","volume":"84","author":"Boichuk","year":"2010","journal-title":"J Virol"},{"key":"2022061706315613500_bib29","doi-asserted-by":"crossref","first-page":"16686","DOI":"10.1073\/pnas.0907862106","article-title":"Ubiquitination of histone H2B regulates chromatin dynamics by enhancing nucleosome stability","volume":"106","author":"Chandrasekharan","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706315613500_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nchembio.501","article-title":"Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction","volume":"7","author":"Fierz","year":"2011","journal-title":"Nat Chem Biol"},{"key":"2022061706315613500_bib31","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.celrep.2016.01.020","article-title":"RNF20 links histone H2B ubiquitylation with inflammation and inflammation-associated cancer","volume":"14","author":"Tarcic","year":"2016","journal-title":"Cell Rep"},{"key":"2022061706315613500_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2005.10.001","article-title":"Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression","volume":"8","author":"Varambally","year":"2005","journal-title":"Cancer Cell"},{"key":"2022061706315613500_bib33","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1158\/0008-5472.CAN-11-2209","article-title":"Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20\/Rnf40) leads to replication stress and chromosomal instability","volume":"72","author":"Chernikova","year":"2012","journal-title":"Cancer Res"},{"key":"2022061706315613500_bib34","first-page":"5460","article-title":"The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20\/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer","volume":"25","author":"Dickson","year":"2016","journal-title":"Hum Mol Genet"},{"key":"2022061706315613500_bib35","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1158\/0008-5472.CAN-11-1896","article-title":"Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B","volume":"71","author":"Prenzel","year":"2011","journal-title":"Cancer Res"},{"key":"2022061706315613500_bib36","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/08820139.2017.1360342","article-title":"Serum IL-6 and IL-8 correlate with prognostic factors in ovarian cancer","volume":"46","author":"Sanguinete","year":"2017","journal-title":"Immunol Invest"},{"key":"2022061706315613500_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The unique molecular and cellular microenvironment of ovarian cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front Oncol"},{"key":"2022061706315613500_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trsl.2015.08.013","article-title":"Therapeutics targeting innate immune\/inflammatory responses through the interleukin-6\/JAK\/STAT signal transduction pathway in patients with cancer","volume":"167","author":"Roxburgh","year":"2016","journal-title":"Transl Res"},{"key":"2022061706315613500_bib39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fonc.2014.00144","article-title":"Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targets","volume":"4","author":"Marsh","year":"2014","journal-title":"Front Oncol"},{"key":"2022061706315613500_bib40","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1158\/0008-5472.CAN-14-1022","article-title":"Epigenetic targeting of ovarian cancer stem cells","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/79\/4\/760\/2787927\/760.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/79\/4\/760\/2787927\/760.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T15:20:48Z","timestamp":1655479248000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/79\/4\/760\/640352\/Early-Loss-of-Histone-H2B-Monoubiquitylation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,2,15]]},"published-print":{"date-parts":[[2019,2,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-18-2297","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22422657.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22422654.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6511296.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6511296","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22422657","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22422654","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]}}}